4.7 Review

The aryl hydrocarbon receptor and the gut-brain axis

Journal

CELLULAR & MOLECULAR IMMUNOLOGY
Volume 18, Issue 2, Pages 259-268

Publisher

CHIN SOCIETY IMMUNOLOGY
DOI: 10.1038/s41423-020-00585-5

Keywords

Aryl hydrocarbon receptor; Autoimmune diseases; Infectious diseases; cancer

Categories

Funding

  1. NIH [NS102807, ES02530, ES029136, AI126880]
  2. NMSS [RG-1902-33606]
  3. International Progressive MS Alliance [PA-1604-08459]
  4. Santander Universidades
  5. FundacAo Faculdade de Medicina (FFM), SAo Paulo, SP, Brazil

Ask authors/readers for more resources

The aryl hydrocarbon receptor (AHR) was originally identified as the receptor for dioxin and is now known to be a receptor for multiple physiological ligands, playing crucial roles in health and disease. AHR has been found to play a role in the gut-brain axis and could hold potential as a therapeutic target for immune-mediated diseases.
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor initially identified as the receptor for dioxin. Almost half a century after its discovery, AHR is now recognized as a receptor for multiple physiological ligands, with important roles in health and disease. In this review, we discuss the role of AHR in the gut-brain axis and its potential value as a therapeutic target for immune-mediated diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available